Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFMW) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Sunshine Biopharma (SBFMW) over the last 14 years, with Q3 2025 value amounting to -$770559.0.

  • Sunshine Biopharma's Net Cash Flow fell 95020.85% to -$770559.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.4 million, marking a year-over-year increase of 6457.11%. This contributed to the annual value of -$5.6 million for FY2024, which is 737.89% up from last year.
  • Per Sunshine Biopharma's latest filing, its Net Cash Flow stood at -$770559.0 for Q3 2025, which was down 95020.85% from $1.8 million recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Net Cash Flow registered a high of $28.5 million during Q2 2022, and its lowest value of -$19.0 million during Q4 2022.
  • For the 5-year period, Sunshine Biopharma's Net Cash Flow averaged around $454076.6, with its median value being -$335777.0 (2021).
  • Per our database at Business Quant, Sunshine Biopharma's Net Cash Flow skyrocketed by 4195955.08% in 2022 and then plummeted by 2527025.18% in 2024.
  • Sunshine Biopharma's Net Cash Flow (Quarter) stood at -$335777.0 in 2021, then crashed by 5547.28% to -$19.0 million in 2022, then soared by 84.23% to -$3.0 million in 2023, then soared by 36.95% to -$1.9 million in 2024, then surged by 59.12% to -$770559.0 in 2025.
  • Its Net Cash Flow was -$770559.0 in Q3 2025, compared to $1.8 million in Q2 2025 and -$1.6 million in Q1 2025.